| Year |
Citation |
Score |
| 2015 |
Mancino MJ, Shervani S, Thostenson JD, Guise JB, McGaugh J, Kosten T, Oliveto A. Cognitive and cardiovascular effects of carvedilol in recently abstinent, cocaine-dependent patients Drug and Alcohol Dependence. 146: e191-e192. DOI: 10.1016/J.Drugalcdep.2014.09.436 |
0.31 |
|
| 2014 |
Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A. Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms. Journal of Clinical Psychopharmacology. 34: 234-9. PMID 24525654 DOI: 10.1097/Jcp.0000000000000062 |
0.376 |
|
| 2014 |
Oliveto A, Thostenson J, Kosten T, Mancino M. Mediators of response to sertraline vs. placebo among recently abstinent, cocaine-dependent patients Drug and Alcohol Dependence. 140: e165-e166. DOI: 10.1016/J.Drugalcdep.2014.02.466 |
0.357 |
|
| 2013 |
Sanders NC, Mancino MJ, Gentry WB, Guise JB, Bickel WK, Thostenson J, Oliveto AH. Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure. Experimental and Clinical Psychopharmacology. 21: 294-302. PMID 23855333 DOI: 10.1037/A0033724 |
0.326 |
|
| 2013 |
Atkinson TS, Sanders N, Mancino M, Oliveto A. Effects of disulfiram on QTc interval in non-opioid-dependent and methadone-treated cocaine-dependent patients. Journal of Addiction Medicine. 7: 243-8. PMID 23648640 DOI: 10.1097/Adm.0B013E3182928E02 |
0.422 |
|
| 2013 |
Oliveto A, Mancino M, Sanders N, Cargile C, Benjamin Guise J, Bickel W, Brooks Gentry W. Effects of prototypic calcium channel blockers in methadone-maintained humans responding under a naloxone discrimination procedure. European Journal of Pharmacology. 715: 424-35. PMID 23524089 DOI: 10.1016/J.Ejphar.2013.03.007 |
0.507 |
|
| 2012 |
Oliveto A, Poling J, Mancino MJ, Williams DK, Thostenson J, Pruzinsky R, Gonsai K, Sofuoglu M, Gonzalez G, Tripathi S, Kosten TR. Sertraline delays relapse in recently abstinent cocaine-dependent patients with depressive symptoms. Addiction (Abingdon, England). 107: 131-41. PMID 21707811 DOI: 10.1111/J.1360-0443.2011.03552.X |
0.363 |
|
| 2011 |
Oliveto A, Poling J, Mancino MJ, Feldman Z, Cubells JF, Pruzinsky R, Gonsai K, Cargile C, Sofuoglu M, Chopra MP, Gonzalez-Haddad G, Carroll KM, Kosten TR. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients. Drug and Alcohol Dependence. 113: 184-91. PMID 20828943 DOI: 10.1016/J.Drugalcdep.2010.07.022 |
0.477 |
|
| 2010 |
Oliveto A, Gentry WB, Pruzinsky R, Gonsai K, Kosten TR, Martell B, Poling J. Behavioral effects of gamma-hydroxybutyrate in humans. Behavioural Pharmacology. 21: 332-42. PMID 20526195 DOI: 10.1097/Fbp.0B013E32833B3397 |
0.447 |
|
| 2010 |
Mancino MJ, McGaugh J, Feldman Z, Poling J, Oliveto A. Effect of PTSD diagnosis and contingency management procedures on cocaine use in dually cocaine- and opioid-dependent individuals maintained on LAAM: a retrospective analysis. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 169-77. PMID 20163389 DOI: 10.1111/j.1521-0391.2009.00025.x |
0.377 |
|
| 2009 |
McGaugh J, Mancino MJ, Feldman Z, Chopra MP, Gentry WB, Cargile C, Oliveto A. Open-label pilot study of modafinil for methamphetamine dependence. Journal of Clinical Psychopharmacology. 29: 488-91. PMID 19745650 DOI: 10.1097/JCP.0b013e3181b591e0 |
0.351 |
|
| 2008 |
Chopra MP, Feldman Z, Mancino MJ, Oliveto A. Sex and opioid maintenance dose influence response to naloxone in opioid-dependent humans: a retrospective analysis. Pharmacology, Biochemistry, and Behavior. 90: 787-96. PMID 18585405 DOI: 10.1016/j.pbb.2008.05.023 |
0.438 |
|
| 2007 |
Sofuoglu M, Poling J, Gonzalez G, Gonsai K, Oliveto A, Kosten TR. Progesterone effects on cocaine use in male cocaine users maintained on methadone: a randomized, double-blind, pilot study. Experimental and Clinical Psychopharmacology. 15: 453-60. PMID 17924779 DOI: 10.1037/1064-1297.15.5.453 |
0.366 |
|
| 2007 |
Poling J, Pruzinsky R, Kosten TR, Gonsai K, Sofuoglu M, Gonzalez G, Oliveto A. Clinical efficacy of citalopram alone or augmented with bupropion in methadone-stabilized patients. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 16: 187-94. PMID 17612822 DOI: 10.1080/10550490701375640 |
0.404 |
|
| 2007 |
González G, Desai R, Sofuoglu M, Poling J, Oliveto A, Gonsai K, Kosten TR. Clinical efficacy of gabapentin versus tiagabine for reducing cocaine use among cocaine dependent methadone-treated patients. Drug and Alcohol Dependence. 87: 1-9. PMID 16930857 DOI: 10.1016/J.Drugalcdep.2006.07.003 |
0.39 |
|
| 2006 |
Poling J, Oliveto A, Petry N, Sofuoglu M, Gonsai K, Gonzalez G, Martell B, Kosten TR. Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. Archives of General Psychiatry. 63: 219-28. PMID 16461866 DOI: 10.1001/Archpsyc.63.2.219 |
0.4 |
|
| 2006 |
Kosten TR, Scanley BE, Tucker KA, Oliveto A, Prince C, Sinha R, Potenza MN, Skudlarski P, Wexler BE. Cue-induced brain activity changes and relapse in cocaine-dependent patients. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 31: 644-50. PMID 16123763 DOI: 10.1038/Sj.Npp.1300851 |
0.349 |
|
| 2005 |
Oliveto A, Poling J, Sevarino KA, Gonsai KR, McCance-Katz EF, Stine SM, Kosten TR. Efficacy of dose and contingency management procedures in LAAM-maintained cocaine-dependent patients. Drug and Alcohol Dependence. 79: 157-65. PMID 16002025 DOI: 10.1016/J.Drugalcdep.2005.01.007 |
0.463 |
|
| 2005 |
Kosten T, Sofuoglu M, Poling J, Gonsai K, Oliveto A. Desipramine treatment for cocaine dependence in buprenorphine- or methadone-treated patients: baseline urine results as predictor of response. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 8-17. PMID 15804873 DOI: 10.1080/10550490590899817 |
0.361 |
|
| 2004 |
Hughes JR, Oliveto AH, Riggs R, Kenny M, Liguori A, Pillitteri JL, MacLaughlin MA. Concordance of different measures of nicotine dependence: two pilot studies. Addictive Behaviors. 29: 1527-39. PMID 15451122 DOI: 10.1016/J.Addbeh.2004.02.031 |
0.381 |
|
| 2004 |
Kosten T, Falcioni J, Oliveto A, Feingold A. Depression predicts higher rates of heroin use on desipramine with buprenorphine than with methadone. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: 191-201. PMID 15204669 DOI: 10.1080/10550490490435966 |
0.326 |
|
| 2004 |
Oliveto A, Poling J, Kosten TR, Gonsai K. Isradipine and dextromethorphan in methadone-maintained humans under a naloxone discrimination procedure. European Journal of Pharmacology. 491: 157-68. PMID 15140632 DOI: 10.1016/J.Ejphar.2004.03.024 |
0.501 |
|
| 2004 |
Gonzalez G, Oliveto A, Kosten TR. Combating opiate dependence: a comparison among the available pharmacological options. Expert Opinion On Pharmacotherapy. 5: 713-25. PMID 15102558 DOI: 10.1517/14656566.5.4.713 |
0.375 |
|
| 2003 |
Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR. Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction (Abingdon, England). 98: 1625-32. PMID 14616189 DOI: 10.1046/J.1360-0443.2003.00544.X |
0.451 |
|
| 2003 |
Gonzalez G, Feingold A, Oliveto A, Gonsai K, Kosten TR. Comorbid major depressive disorder as a prognostic factor in cocaine-abusing buprenorphine-maintained patients treated with desipramine and contingency management. The American Journal of Drug and Alcohol Abuse. 29: 497-514. PMID 14510037 DOI: 10.1081/Ada-120023455 |
0.324 |
|
| 2003 |
Sofuoglu M, Singha A, Kosten TR, McCance-Katz FE, Petrakis I, Oliveto A. Effects of naltrexone and isradipine, alone or in combination, on cocaine responses in humans. Pharmacology, Biochemistry, and Behavior. 75: 801-8. PMID 12957222 DOI: 10.1016/S0091-3057(03)00157-6 |
0.423 |
|
| 2003 |
Oliveto A, Benios T, Gonsai K, Feingold A, Poling J, Kosten TR. D-cycloserine-Naloxone interactions in opioid-dependent humans under a novel-response naloxone discrimination procedure. Experimental and Clinical Psychopharmacology. 11: 237-46. PMID 12940503 DOI: 10.1037/1064-1297.11.3.237 |
0.419 |
|
| 2003 |
Kosten T, Oliveto A, Feingold A, Poling J, Sevarino K, McCance-Katz E, Stine S, Gonzalez G, Gonsai K. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. Drug and Alcohol Dependence. 70: 315-25. PMID 12757969 DOI: 10.1016/S0376-8716(03)00032-2 |
0.406 |
|
| 2003 |
Kosten T, Poling J, Oliveto A. Effects of reducing contingency management values on heroin and cocaine use for buprenorphine- and desipramine-treated patients. Addiction (Abingdon, England). 98: 665-71. PMID 12751984 DOI: 10.1046/J.1360-0443.2003.00380.X |
0.373 |
|
| 2003 |
Oliveto A, Sevarino K, McCance-Katz E, Benios T, Poling J, Feingold A. Clonidine and yohimbine in opioid-dependent humans responding under a naloxone novel-response discrimination procedure. Behavioural Pharmacology. 14: 97-109. PMID 12658070 DOI: 10.1097/01.fbp.0000063525.83818.0c |
0.41 |
|
| 2002 |
Gonzalez G, Oliveto A, Kosten TR. Treatment of heroin (diamorphine) addiction: current approaches and future prospects. Drugs. 62: 1331-43. PMID 12076182 DOI: 10.2165/00003495-200262090-00004 |
0.375 |
|
| 2002 |
Feingold A, Oliveto A, Schottenfeld R, Kosten TR. Utility of crossover designs in clinical trials: efficacy of desipramine vs. placebo in opioid-dependent cocaine abusers. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 11: 111-23. PMID 12028741 DOI: 10.1080/10550490290087884 |
0.43 |
|
| 2002 |
Kosten TR, Oliveto A, Sevarino KA, Gonsai K, Feingold A. Ketoconazole increases cocaine and opioid use in methadone maintained patients. Drug and Alcohol Dependence. 66: 173-80. PMID 11906804 DOI: 10.1016/S0376-8716(01)00198-3 |
0.438 |
|
| 2002 |
Oliveto A, Sevarino K, McCance-Katz E, Feingold A. Butorphanol and nalbuphine in opioid-dependent humans under a naloxone discrimination procedure. Pharmacology, Biochemistry, and Behavior. 71: 85-96. PMID 11812511 DOI: 10.1016/S0091-3057(01)00637-2 |
0.508 |
|
| 2001 |
Oliveto A, McCance-Katz FE, Singha A, Petrakis I, Hameedi F, Kosten TR. Effects of cocaine prior to and during bupropion maintenance in cocaine-abusing volunteers. Drug and Alcohol Dependence. 63: 155-67. PMID 11376920 DOI: 10.1016/S0376-8716(00)00198-8 |
0.407 |
|
| 2000 |
Singha AK, McCance-Katz EF, Petrakis I, Kosten TR, Oliveto A. Sex differences in self-reported and physiological response to oral cocaine and placebo in humans. The American Journal of Drug and Alcohol Abuse. 26: 643-57. PMID 11097197 DOI: 10.1081/Ada-100101900 |
0.395 |
|
| 2000 |
Hughes JR, Oliveto AH, MacLaughlin M. Is dependence on one drug associated with dependence on other drugs? The cases of alcohol, caffeine and nicotine. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 9: 196-201. PMID 11000915 DOI: 10.1080/10550490050148026 |
0.397 |
|
| 2000 |
Sevarino KA, Oliveto A, Kosten TR. Neurobiological adaptations to psychostimulants and opiates as a basis of treatment development. Annals of the New York Academy of Sciences. 909: 51-87. PMID 10911924 DOI: 10.1111/J.1749-6632.2000.Tb06676.X |
0.374 |
|
| 2000 |
Schottenfeld RS, Pakes J, O'Connor P, Chawarski M, Oliveto A, Kosten TR. Thrice-weekly versus daily buprenorphine maintenance. Biological Psychiatry. 47: 1072-9. PMID 10862807 DOI: 10.1016/S0006-3223(99)00270-X |
0.499 |
|
| 1999 |
Oliveto AH, Feingold A, Schottenfeld R, Jatlow P, Kosten TR. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone. Archives of General Psychiatry. 56: 812-20. PMID 12884887 DOI: 10.1001/Archpsyc.56.9.812 |
0.326 |
|
| 1999 |
Singha AK, McCance-Katz EF, Heck SA, Kosten TR, Oliveto A. Individual differences in humans responding under a cocaine discrimination procedure: discriminators versus nondiscriminators. Experimental and Clinical Psychopharmacology. 7: 391-8. PMID 10609974 DOI: 10.1037//1064-1297.7.4.391 |
0.414 |
|
| 1998 |
Oliveto AH, McCance-Katz E, Singha A, Hameedi F, Kosten TR. Effects of d-amphetamine and caffeine in humans under a cocaine discrimination procedure. Behavioural Pharmacology. 9: 207-17. PMID 9832935 |
0.331 |
|
| 1998 |
Oliveto AH, Farren C, Kosten TR. Effect of LAAM dose on opiate use in opioid-dependent patients. A pilot study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 7: 272-82. PMID 9809131 DOI: 10.1111/J.1521-0391.1998.Tb00346.X |
0.362 |
|
| 1998 |
Hughes JR, Oliveto AH, Liguori A, Carpenter J, Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. Drug and Alcohol Dependence. 52: 99-107. PMID 9800139 DOI: 10.1016/S0376-8716(98)00083-0 |
0.411 |
|
| 1998 |
Oliveto AH, Rosen MI, Kosten TA, Hameedi FA, Woods SW, Kosten TR. Hydromorphone-naloxone combinations in opioid-dependent humans under a naloxone novel-response discrimination procedure. Experimental and Clinical Psychopharmacology. 6: 169-78. PMID 9608349 DOI: 10.1037//1064-1297.6.2.169 |
0.376 |
|
| 1997 |
Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Badger G. Functional antagonism of the caffeine-discriminative stimulus by triazolam in humans. Behavioural Pharmacology. 8: 124-38. PMID 9833008 |
0.632 |
|
| 1997 |
Hughes JR, Oliveto AH. A systematic survey of caffeine intake in Vermont. Experimental and Clinical Psychopharmacology. 5: 393-8. PMID 9386966 DOI: 10.1037//1064-1297.5.4.393 |
0.393 |
|
| 1997 |
Schottenfeld RS, Pakes JR, Oliveto A, Ziedonis D, Kosten TR. Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Archives of General Psychiatry. 54: 713-20. PMID 9283506 DOI: 10.1001/Archpsyc.1997.01830200041006 |
0.506 |
|
| 1997 |
Liguori A, Hughes JR, Oliveto AH. Caffeine self-administration in humans: 1. Efficacy of cola vehicle. Experimental and Clinical Psychopharmacology. 5: 286-94. PMID 9260077 DOI: 10.1037//1064-1297.5.3.286 |
0.429 |
|
| 1995 |
Kamien JB, Bickel WK, Oliveto AH, Higgins ST, Hughes JR, Richards AT, Badger GJ. Placebo-effects contribute to differences in the acquisition of drug discrimination by humans: a retrospective analysis. Behavioural Pharmacology. 6: 187-194. PMID 11224326 DOI: 10.1097/00008877-199503000-00011 |
0.605 |
|
| 1995 |
Oliveto A, Kosten TR, Schottenfeld R, Falcioni J, Ziedonis D. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users. Journal of Substance Abuse Treatment. 12: 423-8. PMID 8749726 DOI: 10.1016/0740-5472(95)02015-2 |
0.452 |
|
| 1995 |
Oliveto AH, Rosen MI, Woods SW, Kosten TR. Discriminative stimulus, self-reported and cardiovascular effects of orally administered cocaine in humans. The Journal of Pharmacology and Experimental Therapeutics. 272: 231-41. PMID 7815337 |
0.352 |
|
| 1995 |
Hale KL, Hughes JR, Oliveto AH, Higgins ST. Caffeine self-administration and subjective effects in adolescents Experimental and Clinical Psychopharmacology. 3: 364-370. DOI: 10.1037/1064-1297.3.4.364 |
0.53 |
|
| 1995 |
Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ. The Ability of Low Doses of Caffeine to Serve as Reinforcers in Humans: A Replication Experimental and Clinical Psychopharmacology. 3: 358-363. |
0.47 |
|
| 1994 |
Kamien JB, Bickel WK, Oliveto AH, Smith BJ, Higgins ST, Hughes JR, Badger GJ. Triazolam discrimination by humans under a novel response procedure: effects of buspirone and lorazepam. Behavioural Pharmacology. 5: 315-325. PMID 11224281 DOI: 10.1097/00008877-199406000-00009 |
0.645 |
|
| 1994 |
Oliveto AH, Bickel WK, Kamien JB, Hughes JR, Higgins ST. Effects of diazepam and hydromorphone in triazolam-trained humans under a novel-response drug discrimination procedure. Psychopharmacology. 114: 417-23. PMID 7531852 DOI: 10.1007/BF02249331 |
0.655 |
|
| 1994 |
Oliveto AH, Kosten TR, Schottenfeld R, Ziedonis D, Falcioni J. Cocaine Use in Buprenorphine- vs. Methadone-Maintained Patients The American Journal On Addictions. 3: 43-48. DOI: 10.1111/J.1521-0391.1994.Tb00225.X |
0.355 |
|
| 1993 |
Oliveto AH, Bickel WK, Hughes JR, Terry SY, Higgins ST, Badger GJ. Pharmacological specificity of the caffeine discriminative stimulus in humans: effects of theophylline, methylphenidate and buspirone. Behavioural Pharmacology. 4: 237-246. PMID 11224191 DOI: 10.1097/00008877-199306000-00006 |
0.642 |
|
| 1993 |
Bickel WK, Oliveto AH, Kamien JB, Higgins ST, Hughes JR. A novel-response procedure enhances the selectivity and sensitivity of a triazolam discrimination in humans. The Journal of Pharmacology and Experimental Therapeutics. 264: 360-7. PMID 8423538 |
0.615 |
|
| 1993 |
Hughes JR, Oliveto AH, Bickel WK, Higgins ST, Badger GJ. Caffeine self-administration and withdrawal: incidence, individual differences and interrelationships. Drug and Alcohol Dependence. 32: 239-46. PMID 8348875 DOI: 10.1016/0376-8716(93)90088-8 |
0.583 |
|
| 1993 |
Hughes JR, Oliveto AH. Coffee and alcohol intake as predictors of smoking cessation and tobacco withdrawal. Journal of Substance Abuse. 5: 305-10. PMID 8312736 DOI: 10.1016/0899-3289(93)90072-J |
0.346 |
|
| 1993 |
Oliveto A, Kosten T, Schottenfeld R, Ziedonis D. Cocaine abuse among methadone-maintained patients. The American Journal of Psychiatry. 150: 1755. PMID 8214197 DOI: 10.1176/Ajp.150.11.1755A |
0.325 |
|
| 1992 |
Hughes JR, Oliveto AH, Helzer JE, Higgins ST, Bickel WK. Should caffeine abuse, dependence, or withdrawal be added to DSM-IV and ICD-10? The American Journal of Psychiatry. 149: 33-40. PMID 1728182 DOI: 10.1176/Ajp.149.1.33 |
0.565 |
|
| 1992 |
Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Fenwick JW. Triazolam as a discriminative stimulus in humans. Drug and Alcohol Dependence. 30: 133-42. PMID 1633753 DOI: 10.1016/0376-8716(92)90018-8 |
0.616 |
|
| 1992 |
Oliveto AH, Bickel WK, Hughes JR, Shea PJ, Higgins ST, Fenwick JW. Caffeine drug discrimination in humans: acquisition, specificity and correlation with self-reports. The Journal of Pharmacology and Experimental Therapeutics. 261: 885-94. PMID 1602393 |
0.638 |
|
| 1992 |
Oliveto AH, Hughes JR, Higgins ST, Bickel WK, Pepper SL, Shea PJ, Fenwick JW. Forced-choice versus free-choice procedures: caffeine self-administration in humans. Psychopharmacology. 109: 85-91. PMID 1365676 DOI: 10.1007/BF02245484 |
0.569 |
|
| 1991 |
Oliveto AH, Hughes JR, Terry SY, Bickel WK, Higgins ST, Pepper SL, Fenwick JW. Effects of caffeine on tobacco withdrawal. Clinical Pharmacology and Therapeutics. 50: 157-64. PMID 1868677 DOI: 10.1038/Clpt.1991.120 |
0.529 |
|
| 1991 |
Oliveto AH, Picker MJ, Dykstra LA. Acute and chronic morphine administration: effects of mixed-action opioids in rats and squirrel monkeys responding under a schedule of food presentation. The Journal of Pharmacology and Experimental Therapeutics. 257: 8-18. PMID 1850479 |
0.594 |
|
| 1990 |
Hughes JR, Oliveto AH. The growth of treatment research in alcohol and drug use disorders: a computerized literature search. Drug and Alcohol Dependence. 26: 81-4. PMID 2209418 DOI: 10.1016/0376-8716(90)90085-S |
0.347 |
|
| 1990 |
Oliveto AH, Hughes JR, Pepper SL, Bickel WK, Higgins ST. Low doses of caffeine can serve as reinforcers in humans. Nida Research Monograph. 105: 442. PMID 1876066 |
0.561 |
|
| 1990 |
Hughes JR, Oliveto AH, Higgins ST, Bickel WK. Evidence for and against considering caffeine a drug of dependence Pharmacology Biochemistry and Behavior. 36: 435. DOI: 10.1016/0091-3057(90)90484-Y |
0.533 |
|
| 1990 |
Oliveto AH, Bickel WK, Hughes JR, Higgins ST, Shea P. Caffeine as a discriminative stimulus in humans Pharmacology Biochemistry and Behavior. 36: 428. DOI: 10.1016/0091-3057(90)90454-P |
0.407 |
|
| 1989 |
Picker MJ, Cleary JP, Berens K, Oliveto AH, Dykstra LA. Molindone: effects in pigeons responding under conditional discrimination tasks. Pharmacology, Biochemistry, and Behavior. 32: 439-45. PMID 2727003 DOI: 10.1016/0091-3057(89)90176-7 |
0.517 |
|
| 1989 |
Oliveto A, Picker M, Dykstra LA. Effects of mixed-action opioids on food-maintained behavior of morphine-pretreated and morphine-tolerant rats. Nida Research Monograph. 95: 524. PMID 2561847 |
0.54 |
|
| 1989 |
Oliveto AH, Dykstra LA, Picker MJ. Enhanced sensitivity to mixed-action opioids in morphine-tolerant squirrel monkeys Pharmacology Biochemistry and Behavior. 32: 1087. DOI: 10.1016/0091-3057(89)90124-X |
0.542 |
|
| 1988 |
Oliveto AH, Slifer BL, Dykstra LA. Tripelennamine fails to enhance the morphine-like stimulus effects of pentazocine. Pharmacology, Biochemistry, and Behavior. 29: 397-401. PMID 3362933 DOI: 10.1016/0091-3057(88)90175-X |
0.761 |
|
| 1988 |
Oliveto AH, Dykstra LA. Diprenorphine and naloxone in squirrel monkeys with enhanced sensitivity to opioid antagonists. Psychopharmacology. 95: 339-43. PMID 3137619 DOI: 10.1007/BF00181944 |
0.635 |
|
| 1987 |
Oliveto AH, Dykstra LA. Naloxone sensitivity in squirrel monkeys under a schedule of shock titration. Pharmacology, Biochemistry, and Behavior. 26: 191-3. PMID 3562492 DOI: 10.1016/0091-3057(87)90554-5 |
0.591 |
|
| 1985 |
Oliveto AH, Dykstra LA. Increased sensitivity to the rate-decreasing effects of diprenorphine following frequent exposure to naloxone in squirrel monkeys Federation Proceedings. 44: No. 7659. |
0.509 |
|
| Show low-probability matches. |